Records containing: Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-01A Clinical Study on the Safety and Efficacy of Allogeneic CAR T Cells Targeting BCMA in the Treatment of Adult r/r Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-01Gene Therapy Follow up Protocol for Subjects Previously Enrolled in CAR T-Cell Studies
-
CLINICAL_TRIALS study record update · 2025-12-01Data, Tissue, Blood, and Urine Repository for Amyloid Diseases
-
CLINICAL_TRIALS study record update · 2025-11-28Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma: A Phase 2 Multicenter Study
-
CLINICAL_TRIALS study record update · 2025-11-28A Phase 1, Randomized, Dose and Schedule Evaluation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Belantamab Mafodotin Administered in Combination With Standard of Care in Participants With Newly Diagnosed Multiple Myeloma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-28A Prospective Trial Evaluating Plerixafor-based Mobilization and Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2025-11-26Covid-19 Vaccine Responsiveness in Patients With Multiple Myeloma and Waldenstrom's Macroglobulinemia
-
CLINICAL_TRIALS study record update · 2025-11-26Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
-
CLINICAL_TRIALS study record update · 2025-11-25ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-11-25Exploratory Clinical Study on the Safety and Efficacy of CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-11-24Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
-
CLINICAL_TRIALS study record update · 2025-11-24A Prospective Non-interventional Post-authorization Safety Study (PASS) of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant ("Transplant Noneligible" [TNE])
-
CLINICAL_TRIALS study record update · 2025-11-24A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
-
CLINICAL_TRIALS study record update · 2025-11-21The Effect of Distance Reiki on Patient Reported Quality of Life, Correlated With Changes in Immune Repertoires Among Multiple Myeloma Patients: A Pilot Study
-
CLINICAL_TRIALS study record update · 2025-11-20Carfilzomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clinical and Correlative Phase I/II Dose Escalation Study
-
CLINICAL_TRIALS study record update · 2025-11-20Intracellularly Prepared Chimeric Antigen Receptor T-cell Therapy Targeting CD19 for the Treatment of Relapsed/Refractory Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2025-11-20An Open Label, Phase 1 Study Evaluating the Activity of Modular CAR T for mYeloma
-
CLINICAL_TRIALS study record update · 2025-11-20Registry for Adults With Plasma Cell Disorders (PCD's)
-
CLINICAL_TRIALS study record update · 2025-11-19Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-11-19The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
-
CLINICAL_TRIALS study record update · 2025-11-19Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2025-11-18Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-11-13Microbial Changes in Response to a Plant Based Diet and/or Supplements in SMM/MGUS Patients: A National Multi-Arm Randomized Prospective Telehealth Study Via HealthTree
-
CLINICAL_TRIALS study record update · 2025-11-12Pilot PET Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma